IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Historical Holders from Q2 2019 to Q3 2025

Symbol
IDYA on Nasdaq
CUSIP
45166A102
Type / Class
Equity / Common Stock
Shares outstanding
88.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
94.1M
Holdings value
$2.56B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
216
Number of buys
122
Number of sells
-87
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.1% -16% $113M -$19.7M 7.13M -14.9% BlackRock, Inc. Mar 31, 2025
Capital Research Global Investors 7.5% $165M 6.55M Capital Research Global Investors Jun 30, 2025
JANUS HENDERSON GROUP PLC 7.3% +5.71% $175M $6.04M 6.43M +3.58% JANUS HENDERSON GROUP PLC Sep 30, 2025
Point72 Asset Management, L.P. 5% $80.2M 4.41M Point72 Asset Management, L.P. Jun 6, 2025

Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 94.1M $2.56B -$70M $27.21 216
2025 Q2 96.8M $2.04B +$85M $21.02 200
2025 Q1 93.9M $1.54B +$4.22M $16.38 203
2024 Q4 91.9M $2.36B -$38.9M $25.70 203
2024 Q3 91.9M $2.91B +$266M $31.68 208
2024 Q2 82.5M $2.9B +$113M $35.11 196
2024 Q1 79M $3.47B +$599M $43.88 200
2023 Q4 230K $8.19M -$2.16M $35.58 3
2023 Q3 59.7M $1.61B +$84.4M $26.98 142
2023 Q2 56.5M $1.33B +$271M $23.50 137
2023 Q1 45.5M $625M -$7.33M $13.73 126
2022 Q4 46M $835M +$24.1M $18.17 116
2022 Q3 44.7M $667M +$139M $14.92 108
2022 Q2 35.3M $487M +$8.86M $13.80 89
2022 Q1 34.9M $391M -$45.9M $11.19 98
2021 Q4 33.4M $789M +$19.8M $23.64 106
2021 Q3 32.9M $838M +$191M $25.49 89
2021 Q2 25.4M $533M +$25.3M $20.99 82
2021 Q1 23.8M $559M +$80.3M $23.50 88
2020 Q4 19.6M $274M +$21M $14.00 79
2020 Q3 18.2M $228M +$1.09M $12.56 63
2020 Q2 18.5M $262M +$120M $14.21 64
2020 Q1 10.8M $44.6M -$1.24M $4.12 23
2019 Q4 11.2M $83.6M -$5.01M $7.50 26
2019 Q3 5.49M $48.8M -$1.22M $9.00 23
2019 Q2 5.65M $56.3M +$56.3M $9.96 23